Neuroinflammation and Proteostasis are Modulated by Endogenously Biosynthesized Neuroprotectin D1
Neurodegenerative diseases encompass complex cell signaling disturbances that initially damage neuronal circuits and synapses. Due to multiple protective mechanisms enacted to counteract the onset of neurodegenerative diseases, there is often a prolonged period without noticeable impairments during their initiation. Since severe cognitive deficit or vision loss takes place after that period there is an opportunity to harness endogenous protective mechanisms as potential therapeutic approaches. The activation of the biosynthesis of the docosanoid mediator neuroprotectin D1 (NPD1) is an early response to the upsurge of protein misfolding and other neuroinflammatory events. This overview discusses the potent neuroprotective and inflammation-modulating bioactivity of NPD1. This lipid mediator represents an early response to neurodegenerations, aiming to restore homeostasis.
KeywordsMisfolding Retinal degenerations Alzheimer’s disease Huntington’s disease Epilepsy Docosahexaenoic acid Ataxin-1 Huntingtin CAG repeats APP Bcl-2 proteins
- 16.Marcheselli VL, Hong S, Lukiw WJ, Tian XH, Gronert K, Musto A, Hardy M, Gimenez JM, Chiang N, Serhan CN, Bazan NG (2003) Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J Biol Chem 278(44):43807–43817PubMedCrossRefGoogle Scholar
- 24.Zoghbi HY, Bear MF (2012) Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities. Cold Spring Harb Perspect Biol 4(3)Google Scholar
- 31.Sheets KG, Zhou Y, Ertel MK, Knott EJ, Regan CE Jr, Elison JR, Gordon WC, Gjorstrup P, Bazan NG (2010) Neuroprotectin D1 attenuates laser-induced choroidal neovascularization in mouse. Mol Vis 2(16):320–329Google Scholar